The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kochevar Deborah Turner since 2009.
This trader's CIK number is 1448579.
At the time of last reporting, Kochevar Deborah Turner was the Director of Charles River Laboratories International, Inc.. (stock ticker symbol CRL).
Also see all insider trading activities at Charles River Laboratories International, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CRL | 0 | $0 | 3,526 | $1,433,534 | 2,539 | $417,005 |
| 2020 | CRL | 0 | $0 | 2,319 | $501,467 | 0 | $0 |
| 2018 | CRL | 0 | $0 | 4,066 | $502,923 | 0 | $0 |
| 2017 | CRL | 0 | $0 | 7,370 | $648,036 | 3,140 | $220,710 |
| 2015 | CRL | 0 | $0 | 8,850 | $678,340 | 3,530 | $184,583 |
| 2014 | CRL | 0 | $0 | 9,250 | $491,896 | 4,030 | $174,861 |
| 2013 | CRL | 0 | $0 | 24,713 | $1,134,965 | 24,560 | $911,176 |
| 2011 | CRL | 0 | $0 | 29,650 | $1,203,790 | 29,650 | $935,249 |
| 2009 | CRL | 0 | $0 | 1,900 | $61,757 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | ELAN | 1,000 | $27,950 | 0 | $0 | 0 | $0 |
1. Charles River Laboratories International, Inc. (CRL)
2. Elanco Animal Health Inc (ELAN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-08-06 | CRL | Option Ex | 2,539 | 164.24 | 417,005 |
| 2021-08-06 | CRL | Sale | 3,526 | 406.56 | 1,433,534 |
| 2020-08-07 | CRL | Sale | 2,319 | 216.24 | 501,467 |
| 2018-09-04 | CRL | Sale | 4,066 | 123.69 | 502,923 |
| 2017-05-12 | CRL | Sale | 300 | 88.03 | 26,407 |
| 2017-05-12 | CRL | Option Ex | 3,140 | 70.29 | 220,710 |
| 2017-05-12 | CRL | Sale | 7,070 | 87.92 | 621,629 |
| 2015-08-03 | CRL | Option Ex | 3,530 | 52.29 | 184,583 |
| 2015-08-03 | CRL | Sale | 6,250 | 76.67 | 479,206 |
| 2015-03-02 | CRL | Sale | 2,600 | 76.59 | 199,134 |
| 2014-05-22 | CRL | Sale | 3,100 | 53.30 | 165,245 |
| 2014-05-22 | CRL | Option Ex | 4,030 | 43.39 | 174,861 |
| 2014-05-22 | CRL | Sale | 6,150 | 53.11 | 326,651 |
| 2013-08-02 | CRL | Option Ex | 12,280 | 37.10 | 455,588 |
| 2013-08-02 | CRL | Sale | 10,133 | 45.90 | 465,124 |
| 2013-08-02 | CRL | Sale | 4,447 | 46.03 | 204,717 |
| 2013-08-02 | CRL | Option Ex | 12,280 | 37.10 | 455,588 |
| 2013-08-02 | CRL | Sale | 10,133 | 45.90 | 465,124 |
| 2011-05-09 | CRL | Option Ex | 29,650 | 31.54 | 935,249 |
| 2011-05-09 | CRL | Sale | 29,650 | 40.60 | 1,203,790 |
| 2009-08-11 | CRL | Sale | 1,900 | 32.50 | 61,757 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-11 | ELAN | Buy | 1,000 | 27.95 | 27,950 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kochevar Deborah Turner (Director of Charles River Laboratories International, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.